£14.3m
Seed Fund committed to date
£67.9m
co-investment secured to date
43
investments to date
Fast-tracking research into patient impact
Through advances in technology, we’re on the threshold of a golden age of scientific progress against cancer. Start-ups are one of the fastest ways of translating that progress into impact for patients.
But there’s a funding gap between cutting-edge academic cancer research and a start-up becoming ready for commercial investment. Too many potential treatments, devices and innovations are lost here.
We have an opportunity to deliver huge future impact for patients by supporting start-ups through this gap. Which is why we committed £15m to a Seed Fund which accelerates high-potential, early-stage innovations into patient impact through seed funding, expert networks and business building support. Led by an extraordinary £10m donation from the Garfield Weston Foundation, we have now doubled the fund through philanthropic support, to double its impact.
Any financial returns generated are reinvested in the fund and into more cancer research.
We’re proud to be supporting Cancer Research UK’s work to help bridge the gap between discovery science and the clinic.
Supporting innovative cancer start-ups to succeed
We set out to double the impact of our Seed Fund through £15 million in philanthropic donations from visionary supporters. Thanks to the generosity of the Garfield Weston Foundation and other donors, we have now reached that target, growing the fund to £30 million and enabling us to back even more promising cancer innovations.
With huge thanks to our Cancer Impact Booster donors:
- Garfield Weston Foundation
- Cancer Impact Club members
- Nick and Annette Razey
- The Chris Banton Foundation
Speak to the Philanthropy team to find out more
